Rx (Prescription Medicine)
USD $ 120.00
Cabozanib 20mg Tablet 是一种靶向治疗药物，用于治疗某些类型的癌症。其活性成分 Cabozantinib 通过抑制多种受体酪氨酸激酶（RTKs），这些酪氨酸激酶在肿瘤生长、血管生成（即为肿瘤提供营养的新血管的形成）以及转移（癌症向身体其他部位的扩散）中起关键作用。通过阻断这些通路，Cabozanib 有助于减慢或停止癌症的进展。
Cabozanib 20mg Tablet 主要用于治疗晚期肾细胞癌（肾癌）和对放射性碘治疗不敏感的分化甲状腺癌。它也可能用于其他特定类型的癌症，具体取决于医疗专业人员的判断。
Cabozanib 20mg Tablet 的典型剂量由医生根据具体的癌症类型和病情阶段处方。通常口服服用，可与食物同服或空腹服用。务必严格遵医嘱服用剂量和疗程。
Cabozanib 20mg Tablet 常见的不良反应包括疲劳、腹泻、恶心、呕吐、食欲下降、高血压、皮疹以及手足综合征。严重的不良反应也可能发生，如出现新的或加重的症状，应立即向医生报告。Cabozanib 20mg Tablet 应储存在室温，远离潮湿和热源，并放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Cabozantinib 20 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
